Timeline

About Us

2019
2019

Naica HT & Opal Chip

Logo_SLAS_NPA.png
Laureate of the SLAS New Product Award for the Naica HT and the Opal Chip
2018
2018

Illumina Ventures

logo-illumina-ventures.PNG
Completed 16 Million euros Series A funding with Illumina Ventures & others
2016
2016

Naica System

naica_system.jpeg
Commercial Launch
2015
2015

Biopark de Villejuif

biopark_villejuif.jpeg
Relocation at Villejuif BioPark, a Biotechnlogy Cluster
2014
2014

Innovations

innovation_prizes.jpeg
Laureate of many Awards such as Concours Mondial de l’Innovation, Concours I-Lab, MIT TR Innovator under 35
2013
2013

École Polytechnique

polytechnique.jpeg
Incorporation of the Company
2010
2010

Invention of the technology at Ecole Polytechnique France

Invention of the technology at Ecole Polytechnique France

About us

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System.

Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.

Stilla advises and supports its customers worldwide through its dynamic and multidisciplinary R&D team, with expertise spanning microfluidics, chemistry, molecular biology and computer science. Stilla is continuously looking to innovate with the Naica System and is working on the 2nd generation of the platform to further increase the multiplexing capability and throughput of the system.

Partners and
Distributors

cycloudbio_logo.jpeg
apexbio-logo.jpeg
ThunderBio_logo.jpeg

China & South East Asia

South Korea

Japan

Seeking a partnership with Stilla, contact us at sales@stilla.fr